Published in Immunology on June 01, 1976
IgG and complement receptors on purified mouse eosinophils and neutrophils. Immunology (1981) 1.23
Terminal B cell development as seen in different human myelomas and related disorders. Clin Exp Immunol (1979) 0.95
The response to lipopolysaccharide of mouse spleen lymphocytes fractionated on the basis of surface immunoglobulin and complement receptor using fluorescence-activated cell sorting and rosetting techniques. Immunology (1979) 0.75
Variable region (Fv) determinants on mouse lymphocytes. Immunology (1976) 0.75
Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med (1975) 17.16
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters. Proc Natl Acad Sci U S A (1966) 8.92
Immunoglobulin determinants on the surface of mouse lymphoid cells. Nature (1970) 8.35
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells. J Exp Med (1975) 7.20
Rosette formation by peripheral lymphocytes. Clin Exp Immunol (1970) 6.34
Expression of a receptor for IgM by human T cells in vitro. Eur J Immunol (1975) 5.05
Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med (1973) 5.03
In vivo specific antigen recognition by rosette forming cells. Nature (1970) 4.78
Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55
Evidence for a receptor recognizing antigen complexed immunoglobulin on the surface of activated mouse thymus lymphocytes. Scand J Immunol (1972) 4.50
A modification of the hemolytic plaque assay for use with protein antigens. J Immunol (1968) 4.02
Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells. J Exp Med (1969) 3.53
Immunoglobulin and other surface antigens of cells of the immune system. J Exp Med (1971) 3.50
Studies on actively allergized cells. I. The cyto-dynamics and morphology of rosete-forming lymph node cells in mice and inhibition of rosette-formation with antibody to mouse immunoglobulins. Int Arch Allergy Appl Immunol (1969) 3.00
Membrane immunoglobulins and antigen receptors on B and T lymphocytes. Adv Immunol (1974) 2.99
Opsonic adherence of sensitized ox red cells to human lymphocytes as measured by rosette formation. Int Arch Allergy Appl Immunol (1973) 2.31
The Fc receptor on thymus-derived lymphocytes. I. Detection of a subpopulation of murine T lymphocytes bearing the Fc receptor. J Exp Med (1975) 2.15
Lymphocyte receptors. II. Receptors for rabbit IgM on human T lymphocytes. Immunology (1976) 2.06
Rosette formation by mouse lymphocytes. III. Receptors for immunoglobulin on normal and activated T cells. Clin Exp Immunol (1974) 1.59
Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58
Immunoglobulin determinants on the lymphocytes of normal rabbits. 3. As4 and As6 determinants on individual lymphocytes and the concept of allelic exclusion. Immunology (1971) 1.54
Separation and functional analysis of subpopulations of lymphocytes bearing complement and Fc receptors. Transplant Rev (1975) 1.53
Effect of B-cell mitogens on lymphocyte subpopulations possesing C'3 and Fc receptors. J Exp Med (1974) 1.46
Variation in accessible cell surface immunoglobulin among antibody-firming cells. J Exp Med (1972) 1.44
Rosette formation by mouse lymphocytes. II. T-cell specificities in a CRL subpopulation. Clin Exp Immunol (1974) 1.39
Antigen receptors on the surface of antibody-secreting cells. Nat New Biol (1971) 1.35
Factors influencing the agglutinability of red cells. 3. Physico-chemical studies on ox red cells of different classes of agglutinability. Vet Rec (1967) 0.99
C3 receptor. A marker of a thymus-dependent B-cell subpopulation. Clin Exp Immunol (1975) 0.89
Detection of non-H2 antigen(s) which, like Ia antigens, are associated with the Fc receptor of B lymphocytes. J Exp Med (1975) 0.88
C3 receptors on direct plaque-forming cells. Immunology (1975) 0.79
FLUORESCENT BLOOD CELLS AND ANTI-FLUORESCEIN ANTIBODIES. Bibl Haematol (1964) 0.77
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol (1995) 3.60
The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol (1991) 3.47
Studies on actively allergized cells. I. The cyto-dynamics and morphology of rosete-forming lymph node cells in mice and inhibition of rosette-formation with antibody to mouse immunoglobulins. Int Arch Allergy Appl Immunol (1969) 3.00
Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond B Biol Sci (1994) 2.76
Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nat Genet (1998) 2.23
PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration (1994) 2.21
Lymphocyte receptors. II. Receptors for rabbit IgM on human T lymphocytes. Immunology (1976) 2.06
Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage. J Exp Med (1989) 1.97
A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J (1999) 1.96
Transmission of bovine spongiform encephalopathy and scrapie to mice. J Gen Virol (1992) 1.90
Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet (2001) 1.84
Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc Natl Acad Sci U S A (2001) 1.69
Clinicopathological investigation of primary, uncomplicated maedi-visna virus infection. Vet Rec (1992) 1.59
Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia. Br J Haematol (2001) 1.49
Linkage of the scrapie-associated fibril protein (PrP) gene and Sinc using congenic mice and restriction fragment length polymorphism analysis. J Gen Virol (1987) 1.48
Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol (1981) 1.45
Monoclonal antibodies to intracellular campylobacter-like organisms of the porcine proliferative enteropathies. Vet Rec (1987) 1.44
E-cadherin expression in canine cutaneous histiocytomas. Vet Rec (2008) 1.41
Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. Eur J Immunol (1978) 1.37
Antigen receptors on the surface of antibody-secreting cells. Nat New Biol (1971) 1.35
Uptake of antigen by afferent lymph dendritic cells mediated by antibody. Eur J Immunol (1990) 1.33
Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis. Cell Immunol (1976) 1.28
Nucleotide sequence of EV1, a British isolate of maedi-visna virus. J Gen Virol (1991) 1.28
Detection of BSE infectivity in brain and spleen of experimentally infected sheep. Vet Rec (1996) 1.24
Immunological clearance of 75Se-labelled Trypanosoma brucei in mice. II. Mechanisms in immune animals. Immunology (1980) 1.24
Extraneural competition between different scrapie agents leading to loss of infectivity. Nature (1975) 1.20
Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J Pathol (1992) 1.20
A monoclonal antibody to the HLA-DR product recognizes a polymorphic Ia determinant in mice. Immunology (1981) 1.19
Restoration of specific immunological virginity. Nature (1974) 1.16
Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol (1994) 1.15
Scrapie infection can be established readily through skin scarification in immunocompetent but not immunodeficient mice. J Gen Virol (1996) 1.11
Immunoglobulin determinants on mouse lymphocytes from blood, lymph nodes, bone marrow and thymus. Int Arch Allergy Appl Immunol (1970) 1.11
Marginal zone B cells express CR1 and CR2 receptors. Eur J Immunol (1984) 1.10
Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. I. Histology and weight of lymph nodes, spleen, and thymus. J Natl Cancer Inst (1971) 1.09
Lymphocyte traffic through antigen-stimulated lymph nodes. II. Role of Prostaglandin E2 as a mediator of cell shutdown. Immunology (1981) 1.09
Restoration of T-lymphocyte deficiency with dialysable leucocyte extract. Clin Exp Immunol (1974) 1.09
Transmission of bovine spongiform encephalopathy to mice. Vet Rec (1988) 1.05
Solvent extraction as an adjunct to rendering: the effect on BSE and scrapie agents of hot solvents followed by dry heat and steam. Vet Rec (1998) 1.04
Replication of scrapie in spleens of SCID mice follows reconstitution with wild-type mouse bone marrow. J Gen Virol (1996) 1.01
Cloning and expression in Escherichia coli of DNA encoding a 60 kDa stress protein of Mycobacterium paratuberculosis, the causative agent of Johne's disease. Microbiology (1994) 1.01
Infection of dendritic cells by the Maedi-Visna lentivirus. J Virol (2000) 1.01
Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. 3. Plaque-forming cell response in lymph nodes and spleen. J Natl Cancer Inst (1971) 0.98
Properties of educated T cells for rosette formation and cooperation with B cells. Nat New Biol (1972) 0.98
Lymphocyte traffic through antigen-stimulated lymph nodes. I. Complement activation within lymph nodes initiates cell shutdown. Immunology (1981) 0.98
Lymphocyte traffic through lymph nodes during cell shutdown. Ciba Found Symp (1980) 0.97
In vivo modulation of CD1 and MHC class II expression by sheep afferent lymph dendritic cells. Comparison of primary and secondary immune responses. J Exp Med (1989) 0.95
Specific selection of antigen-reactive lymphocytes into antigenically stimulated lymph nodes in sheep. J Exp Med (1981) 0.95
Thymic dependency of tumor-induced immunodepression. J Natl Cancer Inst (1973) 0.94
Complement receptors and cell associated complement components. Immunol Commun (1977) 0.93
Transmission of bovine spongiform encephalopathy to sheep, goats, and mice. Ann N Y Acad Sci (1994) 0.93
Are Sinc and the PrP gene congruent? Evidence from PrP gene analysis in Sinc congenic mice. J Gen Virol (1992) 0.93
Antigen presentation in the sheep: generation of antigen-specific T-cell lines. Immunology (1989) 0.92
Closely similar values obtained when the ME7 strain of scrapie agent was titrated in parallel by two individuals in separate laboratories using two sublines of C57BL mice. J Virol Methods (2000) 0.91
Observations on thermostable subpopulations of the unconventional agents that cause transmissible degenerative encephalopathies. Vet Microbiol (1998) 0.91
Identification of a putative cellular receptor for the lentivirus visna virus. J Gen Virol (1991) 0.91
Two B cell subpopulations have distinct recirculation characteristics. Eur J Immunol (1998) 0.89
Transmission of feline spongiform encephalopathy to mice. Vet Rec (1994) 0.89
Immunoglobulins M and D as antigen-binding receptors on the same cell, with shared specificity. Eur J Immunol (1976) 0.88
Expression of maedi-visna virus major core protein, p25: development of a sensitive p25 antigen detection assay. J Virol Methods (1992) 0.88
Reactivity of the CD11/CD18 workshop monoclonal antibodies in the sheep. Vet Immunol Immunopathol (1993) 0.87
Survival of scrapie agent after exposure to sodium dodecyl sulphate and heat. Vet Microbiol (1999) 0.87
Target lymphoid cell population of carcinogen induced immunodepression in mice. Nature (1970) 0.87
Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue. J Virol (1993) 0.86
Non-random migration of CD4 and CD8 T cells: changes in the CD4: CD8 ratio and interleukin 2 responsiveness of efferent lymph cells following in vivo antigen challenge. Eur J Immunol (1989) 0.86
The effect of formic acid on BSE and scrapie infectivity in fixed and unfixed brain-tissue. Vet Microbiol (1997) 0.86
Mitogenic stimulation of the host enhances susceptibility to scrapie. Nature (1978) 0.86
Autoclaving does not decontaminate formol-fixed scrapie tissues. Lancet (1988) 0.85
Identification of the sheep homologue of the monocyte cell surface molecule--CD14. Vet Immunol Immunopathol (1996) 0.85
One Health in the context of medical and veterinary education. Rev Sci Tech (2014) 0.84
Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction. Immunology (1978) 0.84
Inactivation of the 22A strain of scrapie agent by autoclaving in sodium hydroxide. Vet Microbiol (1997) 0.84
Circulating cytotoxic T lymphocyte precursors in maedi-visna virus-infected sheep. J Gen Virol (1994) 0.84
Oxidative and nitrosative responses of the chicken macrophage cell line MQ-NCSU to experimental Salmonella infection. Br Poult Sci (2005) 0.83
Evidence for the expression of two distinct MHC class II DR beta like molecules in the sheep. Anim Genet (1994) 0.83
Phenotypic analysis of lymphocyte populations in the lungs and regional lymphoid tissue of sheep naturally infected with maedi visna virus. Clin Exp Immunol (1992) 0.83
Studies on actively allergized cells. IV. Light and electron microscopic studies on the morphology of rosette-forming cells with special reference to plasma cells. Immunology (1973) 0.82
Initial lentivirus-host interactions within lymph nodes: a study of maedi-visna virus infection in sheep. J Virol (1995) 0.82
Immunology. Roving lymphocytes. Nature (1983) 0.82
Distinct populations of class II molecules identified by monoclonal antibodies. Clin Exp Immunol (1983) 0.82
Malignant cells isolated from Burkitt's lymphoma but not other forms of leukemia activate the alternative complement pathway in human serum. Eur J Immunol (1981) 0.81
Characterization of monoclonal antibodies specific for alpha- and beta-chains of sheep MHC class II. Immunology (1990) 0.81
The restricted IgG1 antibody response to maedi visna virus is seen following infection but not following immunization with recombinant gag protein. Clin Exp Immunol (1995) 0.81
Biochemical and phenotypic characterization of the ovine beta 2 (leucocyte) integrins. J Comp Pathol (1995) 0.80
Patterns of major histocompatibility complex class II expression by T cell subsets in different immunological compartments. 2. Altered expression and cell function following activation in vivo. Eur J Immunol (1993) 0.80
CD4(+) T-cells are required for the establishment of maedi-visna virus infection in macrophages but not dendritic cells in vivo. Virology (1999) 0.79
Different rates of interleukin 2 receptor expression by ovine gamma/delta and alpha/beta T cells. Vet Immunol Immunopathol (1993) 0.79
Interferon amplifies complement activation by Burkitt's lymphoma cells. Nature (1985) 0.79
Immunological aspects of lymphocyte recirculation. Vet Immunol Immunopathol (1984) 0.79
Lymphocyte subpopulations in the blood of sheep persistently infected with border disease virus. Clin Exp Immunol (1989) 0.79
Studies on actively allergised cells. 3. Suppression of the allergic response with specific antibody and the effect of this treatment on plaque and rosette-forming cells. Int Arch Allergy Appl Immunol (1971) 0.79
IL-2-like activity in lymph fluid following in vivo antigen challenge. Immunology (1990) 0.78
Afferent lymph dendritic cells: a model for antigen capture and presentation in vivo. Int Rev Immunol (1990) 0.78
Antigen-induced non-specific suppressor factor in sheep efferent lymph is prostaglandin E2. Immunology (1981) 0.78
A single amino acid alteration in murine PrP dramatically alters TSE incubation time. Arch Virol Suppl (2000) 0.78
Early events in infection of lymphoid tissue by a lentivirus, maedi-visna. Trends Microbiol (1995) 0.78
Characteristics of the T cell-mediated immune response to maedi-visna virus. Virology (1992) 0.78
Patterns of major histocompatibility complex class II expression on T cell subsets in different immunological compartments. 1. Expression on resting T cells. Eur J Immunol (1993) 0.78